Back to search

Kaerus Bioscience Limited

10274924

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

2ND FLOOR, LONDON, E1 6RA
Incorporated 12/07/2016

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Robert Ring

director · Since 12/03/2019

CEO

AMERICAN · UNITED STATES · Age 58

Mr Francesco De Rubertis

director · Since 25/06/2021

INVESTOR

ITALIAN · SWITZERLAND · Age 56

Guenaelle Levoir

director · Since 01/04/2026

FRENCH · FRANCE · Age 61

Persons with Significant Control

Former PSCs

The Cambridge Partnership Limited

Ceased 14/10/2016

CompanyRankvs 163+ SIC 72110 peers
82

Financial strength94th percentile among SIC peers · 24/25
Employees87th percentile among SIC peers · 13/15
LiquidityCurrent ratio 6.78× · 20/20
Longevity10 years trading (max 15) · 10/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees13/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity10/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

£1.8M

Balance sheet strength

Cash

£2.1M

Cash in the bank

Net Current Assets

£1.8M

Working capital

Current Assets

£2.1M

Current Liabilities

£317k

Debtors

£94k

6avg. employees+6
Prepared with Caseware UK (AP4) 2024.0.164

EstimatesDerived

YearCurrent RatioImplied Profit
20246.78-£245k
20234.47+£2.9M
20210.11-£956k
20201.36-£831k
20193.42+£1.0M
20180.81

Derived from filed accounts. Not audited figures.